Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ADI Diagnostics is an Indian healthcare company specializing in the development, manufacture, and marketing of in-vitro diagnostic (IVD) products. The company provides a comprehensive portfolio of rapid diagnostic tests, biochemistry reagents, and serology kits targeting a wide range of conditions, including infectious diseases like Malaria, HIV, Hepatitis, and Dengue. In addition to infectious disease testing, ADI Diagnostics offers solutions for hormone monitoring and cardiac markers such as Troponin I. Serving clinical laboratories and hospitals globally, the company focuses on delivering affordable and reliable diagnostic tools. ADI Diagnostics is also expanding its research and development efforts into advanced platforms such as molecular diagnostics (PCR) and chemiluminescence immunoassays (CLIA).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ADI Diagnostics.